Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 USD | -2.92% | -5.41% | -28.19% |
10/05 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
09/05 | Health Catalyst Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.19% | 39Cr | |
-18.99% | 22TCr | |
-5.49% | 6.92TCr | |
-0.10% | 5.83TCr | |
-11.63% | 4.6TCr | |
+0.61% | 4.08TCr | |
-1.76% | 3.59TCr | |
-9.56% | 2.87TCr | |
+98.90% | 2.61TCr | |
+4.37% | 2.19TCr |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- KeyBanc Upgrades Health Catalyst to Overweight From Sector Weight, Sets Price Target at $16, Cites Early Signs of Improvement in Hospital End Markets